CD33 and allergic rhinitis: For instance, a study conducted by Shiteng Duan in 2019 demonstrated that CD33 recruitment can attenuate IgE-mediated allergic reactions and desensitize mast cells to allergens (88), thereby slowing down the progression of allergic rhinitis.